FineMark National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.53M | Sell |
28,437
-491
| -2% | -$23.6K | 0.05% | 195 |
|
|
2025
Q3 | $1.3M | Sell |
28,928
-1,752
| -6% | -$81.8K | 0.04% | 206 |
|
|
2025
Q2 | $1.42M | Sell |
30,680
-3,539
| -10% | -$174K | 0.05% | 188 |
|
|
2025
Q1 | $2.09M | Sell |
34,219
-837
| -2% | -$48.8K | 0.08% | 153 |
|
|
2024
Q4 | $1.98M | Sell |
35,056
-3,033
| -8% | -$169K | 0.07% | 151 |
|
|
2024
Q3 | $1.97M | Buy |
38,089
+5,848
| +18% | +$274K | 0.07% | 149 |
|
|
2024
Q2 | $1.34M | Sell |
32,241
-9,131
| -22% | -$409K | 0.05% | 174 |
|
|
2024
Q1 | $2.24M | Sell |
41,372
-2,079
| -5% | -$106K | 0.08% | 140 |
|
|
2023
Q4 | $2.23M | Sell |
43,451
-9,202
| -17% | -$483K | 0.09% | 138 |
|
|
2023
Q3 | $3.06M | Sell |
52,653
-790
| -1% | -$48.4K | 0.13% | 126 |
|
|
2023
Q2 | $3.42M | Buy |
53,443
+915
| +2% | +$61.4K | 0.14% | 124 |
|
|
2023
Q1 | $3.64M | Buy |
52,528
+4,270
| +9% | +$301K | 0.16% | 117 |
|
|
2022
Q4 | $3.47M | Sell |
48,258
-13,432
| -22% | -$1.01M | 0.16% | 116 |
|
|
2022
Q3 | $4.39M | Buy |
61,690
+96
| +0.2% | +$6.96K | 0.21% | 109 |
|
|
2022
Q2 | $4.74M | Sell |
61,594
-622
| -1% | -$47.4K | 0.21% | 103 |
|
|
2022
Q1 | $4.54M | Sell |
62,216
-3,349
| -5% | -$225K | 0.18% | 117 |
|
|
2021
Q4 | $4.09M | Sell |
65,565
-47,427
| -42% | -$2.78M | 0.15% | 120 |
|
|
2021
Q3 | $6.69M | Sell |
112,992
-4,499
| -4% | -$296K | 0.28% | 84 |
|
|
2021
Q2 | $7.85M | Sell |
117,491
-3,748
| -3% | -$244K | 0.32% | 73 |
|
|
2021
Q1 | $7.65M | Sell |
121,239
-946
| -0.8% | -$58.9K | 0.32% | 71 |
|
|
2020
Q4 | $7.58M | Sell |
122,185
-4,472
| -4% | -$275K | 0.34% | 66 |
|
|
2020
Q3 | $7.64M | Buy |
126,657
+336
| +0.3% | +$20.2K | 0.37% | 59 |
|
|
2020
Q2 | $7.43M | Buy |
126,321
+1,820
| +1% | +$109K | 0.41% | 58 |
|
|
2020
Q1 | $6.94M | Sell |
124,501
-2,537
| -2% | -$155K | 0.44% | 61 |
|
|
2019
Q4 | $8.15M | Buy |
127,038
+12,430
| +11% | +$712K | 0.41% | 65 |
|
|
2019
Q3 | $5.81M | Sell |
114,608
-2,522
| -2% | -$119K | 0.31% | 73 |
|
|
2019
Q2 | $5.31M | Buy |
117,130
+3,185
| +3% | +$148K | 0.3% | 79 |
|
|
2019
Q1 | $5.44M | Sell |
113,945
-6,424
| -5% | -$320K | 0.32% | 76 |
|
|
2018
Q4 | $6.26M | Sell |
120,369
-2,511
| -2% | -$135K | 0.42% | 65 |
|
|
2018
Q3 | $7.63M | Sell |
122,880
-5,302
| -4% | -$315K | 0.46% | 51 |
|
|
2018
Q2 | $7.09M | Buy |
128,182
+3,247
| +3% | +$175K | 0.43% | 53 |
|
|
2018
Q1 | $7.9M | Buy |
124,935
+258
| +0.2% | +$16.6K | 0.5% | 46 |
|
|
2017
Q4 | $7.64M | Sell |
124,677
-2,233
| -2% | -$140K | 0.49% | 45 |
|
|
2017
Q3 | $8.09M | Buy |
126,910
+4,487
| +4% | +$262K | 0.54% | 40 |
|
|
2017
Q2 | $6.82M | Sell |
122,423
-3,106
| -2% | -$169K | 0.49% | 46 |
|
|
2017
Q1 | $6.83M | Buy |
125,529
+12,814
| +11% | +$703K | 0.5% | 43 |
|
|
2016
Q4 | $6.59M | Buy |
112,715
+5,147
| +5% | +$281K | 0.53% | 44 |
|
|
2016
Q3 | $5.8M | Buy |
107,568
+43,145
| +67% | +$2.77M | 0.62% | 46 |
|
|
2016
Q2 | $4.74M | Buy |
64,423
+2,694
| +4% | +$190K | 0.53% | 53 |
|
|
2016
Q1 | $3.94M | Sell |
61,729
-822
| -1% | -$51.8K | 0.46% | 62 |
|
|
2015
Q4 | $4.3M | Sell |
62,551
-457
| -0.7% | -$30.2K | 0.51% | 53 |
|
|
2015
Q3 | $3.73M | Sell |
63,008
-2,088
| -3% | -$132K | 0.5% | 57 |
|
|
2015
Q2 | $4.33M | Buy |
65,096
+1,429
| +2% | +$94.2K | 0.57% | 52 |
|
|
2015
Q1 | $4.11M | Sell |
63,667
-2,751
| -4% | -$172K | 0.56% | 51 |
|
|
2014
Q4 | $3.92M | Buy |
66,418
+1,022
| +2% | +$57.6K | 0.58% | 47 |
|
|
2014
Q3 | $3.35M | Sell |
65,396
-1,007
| -2% | -$50.3K | 0.54% | 48 |
|
|
2014
Q2 | $3.22M | Buy |
66,403
+4,564
| +7% | +$225K | 0.54% | 45 |
|
|
2014
Q1 | $3.21M | Buy |
61,839
+2,612
| +4% | +$139K | 0.6% | 40 |
|
|
2013
Q4 | $3.15M | Sell |
59,227
-154
| -0.3% | -$7.84K | 0.65% | 35 |
|
|
2013
Q3 | $2.75M | Sell |
59,381
-1,953
| -3% | -$85.7K | 0.68% | 32 |
|
|
2013
Q2 | $2.74M | Buy |
+61,334
| New | +$2.66M | 0.83% | 26 |
|
Other funds holding BMY
FineMark National Bank & Trust's BMY Position: Q4 2025 in Review
FineMark National Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q4 2025, selling an estimated $23.6K and leaving 28,437 shares worth $1.53M. The position accounts for 0.05% of the portfolio, ranked #195.
FineMark National Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.15M in Q4 2019. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- FineMark National Bank & Trust held 28,437 shares of Bristol-Myers Squibb worth $1.53M as of Q4 2025.
- FineMark National Bank & Trust sold 491 Bristol-Myers Squibb shares in Q4 2025, an estimated $23.6K.
- Bristol-Myers Squibb made up 0.05% of FineMark National Bank & Trust's portfolio in Q4 2025, its #195 holding.
- FineMark National Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- FineMark National Bank & Trust's Bristol-Myers Squibb position peaked at $8.15M in Q4 2019.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.